Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sofinnova Ventures
Biotech
The rise of venture debt in biotech and when to use it
There's a time and a place for everything, and right now might be the time for venture debt as biotechs operate on razor-thin margins.
Gabrielle Masson
Jan 24, 2023 10:05am
JPM Day 2: BioNTech tackling symptomatic COVID, Editas' new plan
Jan 10, 2023 3:26pm
Software for the DNA hardware: Chroma snags $125M for epigenome
Nov 17, 2021 6:00am
Eyeing phase 3, Atsena raises $55M financing for gene therapy
Dec 16, 2020 7:30am
Pfizer-backed Bolt Therapeutics strikes $93.5M funding round
Jul 2, 2020 7:10am
Novo helps lead Checkmate's $85M raise for single asset
Jun 11, 2020 7:30am
